EASY MOLECULAR TESTING Trademark
EASY MOLECULAR TESTING is a USPTO trademark filed by BioGX, Inc.. Status: Cancelled.
Trademark Facts
| Mark | EASY MOLECULAR TESTING |
|---|---|
| Serial Number | 87803883 |
| Registration Number | 5688938 |
| Status | Cancelled |
| Filing Date | 2018-02-20 |
| Registration Date | 2019-03-05 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals), 005 (Pharmaceuticals) |
| Owner | BioGX, Inc. |
| Attorney of Record | Mark P Kahler |
| Prosecution Events | 19 |
| Latest Event | C8.. on 2025-09-19 |
Goods & Services
Class 001: Reagents, namely, reagents for medical research testing or for scientific research use; molecular reagents, namely, lyophilized reagents for chemical testing purposes in scientific research; molecular reagents, namely, custom lyophilized reagents for chemical testing for scientific or medical research purposes; molecular reagents, namely, lyophilized reagents for chemical testing purposes, namely, for clinical laboratory use, food safety testing, pharmaceutical testing and water quality analysis for scientific research purposes; molecular reagents, namely, molecular diagnostic reagents for scientific or research use in connection with genetic materials; molecular reagents, namely, molecular reagents for use in real-time PCR and nucleic sequencing platforms for scientific or medical research use; Class 005: Reagents, namely, reagents for medical diagnostic testing use; molecular reagents, namely, lyophilized reagents for chemical testing purposes for medical or veterinary use; molecular reagents, namely, custom lyophilized reagents for chemical testing purposes for medical or veterinary use; molecular reagents, namely, lyophilized reagents for chemical testing purposes, namely, clinical medical reagents and chemical reagents for medicinal pharmaceutical use; molecular reagents, namely, molecular reagents for medical diagnostic use in connection with genetic materials; molecular reagents, namely, molecular reagents for medical diagnostic use in real-time PCR and nucleic sequencing platforms